AI software developer Ezra has raised $21 million in new funding to expand the company's AI-powered technology for full-body MRI scanning into more North American health centers.
The latest investment brings Ezra’s total funding to $41 million, according to the vendor. Ezra said it plans to expand to 20 cities and 50 locations across North America in 2024, as well as advance the use of its AI technology by imaging centers and clinicians.
The funding round was co-led by Healthier Capital and FirstMark Capital and had participation from Allianz Life Ventures, the Schwarzman family, former Chairman of England’s National Health Service (NHS) Lord David Prior, Gaingels, Republic, and Mana Ventures. Existing investors Credo Ventures, Seedcamp, LDV Capital, Accomplice, Founders Future, Vlad Tenev, Anne Wojcicki, and Esther Dyson also participated.
Also as a result of this funding round, Amir Dan Rubin, former CEO of Amazon’s One Medica will also join Ezra’s board of directors.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
